Targeting oxidative stress, a crucial challenge in renal transplantation outcome

Area of Science:

• Biomedical Science
• Pathophysiology
• Pharmacology

Background:

• Ischemia/reperfusion (I/R) injury is a primary cause of organ damage and failure in conditions like stroke, cardiovascular events, acute kidney injury, and organ transplantation.
• The reperfusion phase, involving a sudden increase in oxygen supply after blood flow arrest, induces massive oxidative stress, leading to cell death and tissue damage.
• Reactive oxygen species (ROS) and nitric oxides (NO) are key contributors to cellular damage during I/R injury when endogenous antioxidant defenses are overwhelmed.

Purpose of the Study:

• To review the critical role of oxidative stress in ischemia/reperfusion (I/R) injury.
• To identify key molecular players involved in oxidative stress during I/R.
• To highlight potential pharmacological targets for mitigating I/R-induced damage.

Main Methods:

• Literature review focusing on oxidative stress mechanisms in I/R injury.
• Analysis of the involvement of reactive oxygen species (ROS) and nitric oxides (NO) in cellular damage.
• Identification of endogenous antioxidant systems and their dysregulation in I/R.

Main Results:

• Oxidative stress, driven by ROS and NO accumulation, is a central mechanism in I/R-induced cell death and tissue injury.
• Non-physiological conditions during I/R overwhelm endogenous antioxidant defenses, exacerbating damage.
• Understanding these oxidative pathways is crucial for developing effective treatments.

Conclusions:

• Oxidative stress is a critical determinant of outcomes in ischemia/reperfusion (I/R) pathologies, including organ transplantation.
• Key molecular mediators of oxidative stress represent promising targets for novel pharmacological interventions.
• Developing treatments to prevent or reduce oxidative stress is essential for improving graft survival and function in organ transplantation.